Atypical Breast Proliferative Lesions and Benign Breast Disease
The days of surgical excision for any atypical lesion have been replaced by more nuanced decision making and individualized patient management. Current management of many of these lesions continues to be controversial in regard to observation with close surveillance versus the need for surgical exci...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2018.
|
Έκδοση: | 1st ed. 2018. |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- The Spectrum of Risk Lesions in Breast Pathology: Risk Factors or Cancer Precursors?
- Lobular Carcinoma In Situ: Risk Factor or Cancer Precursor?
- Ductal Carcinoma In Situ: Risk Factor or Cancer
- Diagnostic Management of Papillomas, Radial Scars, and Flat Epithelial Atypia: Core Biopsy Alone Versus Core Biopsy Plus Excision
- Diagnostic Management of Fibroepithelial Lesions: When Is Excision Indicated?
- Diagnostic Management of the Atypical Hyperplasias: Core Biopsy Alone vs Excisional Biopsy
- Diagnostic management of LCIS: Core biopsy alone versus core biopsy plus excision for classic versus pleomorphic LCIS
- Breast Cancer Risk Prediction in Women with Atypical Breast Lesions
- Advanced Screening Options and Surveillance in Women with Atypical Breast Lesions
- The Role of Chemoprevention in the Prevention of Breast Cancer
- Prophylactic Mastectomy in Patients with Atypical Breast Lesions
- The Non-surgical Management of Ductal Carcinoma in Situ (DCIS)
- Surgical Treatment of Ductal Carcinoma in Situ. .